Severe abacavir hypersensitivity reaction in a patient tested HLA-B*5701 negative

被引:14
作者
Bonta, Peter I. [1 ]
Vermeulen, Loost N. [1 ]
Speelman, Peter [1 ]
Prins, Jan M. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1097/QAD.0b013e3283065ba1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1522 / 1523
页数:2
相关论文
共 9 条
[1]   Updated clinical risk factor analysis of suspected hypersensitivity reactions to abacavir [J].
Cutrell, AG ;
Hernandez, JE ;
Fleming, JW ;
Edwards, MT ;
Moore, MA ;
Brothers, CH ;
Scott, TR .
ANNALS OF PHARMACOTHERAPY, 2004, 38 (12) :2171-2172
[2]   Severe rhabdomyolysis during a hypersensitivity reaction to abacavir in a patient treated with ciprofibrate [J].
Fontaine, C ;
Guiard-Schmid, JB ;
Slama, L ;
Essid, A ;
Lukiana, T ;
Rondeau, E ;
Pialoux, G .
AIDS, 2005, 19 (16) :1927-1928
[3]   Genetic variations in HLA-B region and hypersensitivity reactions to abacavir [J].
Hetherington, S ;
Hughes, AR ;
Mosteller, M ;
Shortino, D ;
Baker, KL ;
Spreen, W ;
Lai, E ;
Davies, K ;
Handley, A ;
Dow, DJ ;
Fling, ME ;
Stocum, M ;
Bowman, C ;
Thurmond, LM ;
Roses, AD .
LANCET, 2002, 359 (9312) :1121-1122
[4]   Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir [J].
Hetherington, S ;
McGuirk, S ;
Powell, G ;
Cutrell, A ;
Naderer, O ;
Spreen, B ;
Lafon, S ;
Pearce, G ;
Steel, H .
CLINICAL THERAPEUTICS, 2001, 23 (10) :1603-1614
[5]   Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir [J].
Mallal, S ;
Nolan, D ;
Witt, C ;
Masel, G ;
Martin, AM ;
Moore, C ;
Sayer, D ;
Castley, A ;
Mamotte, C ;
Maxwell, D ;
James, I ;
Christiansen, FT .
LANCET, 2002, 359 (9308) :727-732
[6]   HLA-B*5701 screening for hypersensitivity to abacavir [J].
Mallal, Simon ;
Phillips, Elizabeth ;
Carosi, Giampiero ;
Molina, Jean-Michel ;
Workman, Cassy ;
Tomazic, Janez ;
Jaegel-Guedes, Eva ;
Rugina, Sorin ;
Kozyrev, Oleg ;
Cid, Juan Flores ;
Hay, Phillip ;
Nolan, David ;
Hughes, Sara ;
Hughes, Arlene ;
Ryan, Susanna ;
Fitch, Nicholas ;
Thorborn, Daren ;
Benbow, Alastair .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (06) :568-579
[7]   Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant [J].
Martin, AM ;
Nolan, D ;
Gaudieri, S ;
Almeida, CA ;
Nolan, R ;
James, I ;
Carvalho, F ;
Phillips, E ;
Christiansen, FT ;
Purcell, AW ;
McCluskey, J ;
Mallal, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (12) :4180-4185
[8]   Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV Cohort study [J].
Rauch, A. ;
Nolan, D. ;
Martin, A. ;
McKinnon, E. ;
Almeida, C. ;
Mallal, Simon .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (01) :99-102
[9]   Prospective HLA-B*5701 screening and abacavir hypersensitivity: a single centre experience [J].
Waters, Laura J. ;
Mandalia, Sundhiya ;
Gazzard, Brian ;
Nelson, Mark .
AIDS, 2007, 21 (18) :2533-2534